AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00519233
Recruitment Status : Completed
First Posted : August 22, 2007
Last Update Posted : May 2, 2014
Agensys, Inc.
Information provided by (Responsible Party):
Astellas Pharma Inc